1. Home
  2. HXHX vs SYBX Comparison

HXHX vs SYBX Comparison

Compare HXHX & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HXHX
  • SYBX
  • Stock Information
  • Founded
  • HXHX 2003
  • SYBX N/A
  • Country
  • HXHX China
  • SYBX United States
  • Employees
  • HXHX N/A
  • SYBX N/A
  • Industry
  • HXHX Trucking Freight/Courier Services
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HXHX Industrials
  • SYBX Health Care
  • Exchange
  • HXHX Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • HXHX 16.8M
  • SYBX 20.0M
  • IPO Year
  • HXHX 2025
  • SYBX N/A
  • Fundamental
  • Price
  • HXHX $1.27
  • SYBX $1.82
  • Analyst Decision
  • HXHX
  • SYBX
  • Analyst Count
  • HXHX 0
  • SYBX 0
  • Target Price
  • HXHX N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • HXHX 179.3K
  • SYBX 22.6K
  • Earning Date
  • HXHX 11-20-2025
  • SYBX 11-11-2025
  • Dividend Yield
  • HXHX N/A
  • SYBX N/A
  • EPS Growth
  • HXHX N/A
  • SYBX N/A
  • EPS
  • HXHX 0.26
  • SYBX N/A
  • Revenue
  • HXHX $25,571,810.00
  • SYBX N/A
  • Revenue This Year
  • HXHX N/A
  • SYBX N/A
  • Revenue Next Year
  • HXHX N/A
  • SYBX N/A
  • P/E Ratio
  • HXHX $4.88
  • SYBX N/A
  • Revenue Growth
  • HXHX N/A
  • SYBX N/A
  • 52 Week Low
  • HXHX $0.84
  • SYBX $0.90
  • 52 Week High
  • HXHX $6.29
  • SYBX $1.96
  • Technical
  • Relative Strength Index (RSI)
  • HXHX N/A
  • SYBX 62.59
  • Support Level
  • HXHX N/A
  • SYBX $1.59
  • Resistance Level
  • HXHX N/A
  • SYBX $1.74
  • Average True Range (ATR)
  • HXHX 0.00
  • SYBX 0.08
  • MACD
  • HXHX 0.00
  • SYBX -0.00
  • Stochastic Oscillator
  • HXHX 0.00
  • SYBX 91.02

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: